We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Apax Global Alpha Limited (APAX) Ord NPV

Sell:145.60p Buy:147.00p 0 Change: No change
FTSE 250:0.37%
Market closed Prices as at close on 28 March 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend
Sell:145.60p
Buy:147.00p
Change: No change
Market closed Prices as at close on 28 March 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend
Sell:145.60p
Buy:147.00p
Change: No change
Market closed Prices as at close on 28 March 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Objective

To provide shareholders with superior long-term returns through capital appreciation and regular dividend by investing in a diversified private equity portfolio across four core sectors, as well as a focused portfolio of debt and equity investments.
Security Weight
Assured Partners 0.00%
Toi Toi & Dixi 0.00%
Candela Corp Shs Stock Settlement 0.00%
Pib Group 0.00%
Trade Me 0.00%
Paycor 0.00%
Bonterra 0.00%
Cole Haan 0.00%
Thoughtworks 0.00%
Helpsystems 0.00%

Top 10 sectors currently unavailable.

Top 10 countries currently unavailable.

Fee Structure

The annual fee will be 1% p.a. for Derived Debt and 0.5% p.a. for Derived Equity and Eligible Private Equity. The performance fee rate will be 15% for Derived Debt, with a hurdle rate of 6%. For Derived Equities and Eligible Private Equity, the rate remains at 20% with the hurdle rate of 8% .

Dividend Policy

The Company targets the payment of a dividend equal to 5% of the NAV p.a..The dividend is paid semi-annually.

ASSET SPLIT

Total number of holdings: 59.

Trust Manager

Not Disclosed

Manager Bio

Not currently available for this investment trust.

Board Of Directors

Timothy BreedonChairman, Karl Sternberg, Sally-Ann Farnon, Michael Bane, Stephanie Coxon

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Objective, holding data, trust manager and bio information, dividend policy, asset split and fee structure are provided by Morningstar.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.